New for 2017: MSFHR Innovation to Commercialization Program
16 December 2016
British Columbian researchers generate many potential treatments and cures that could improve health outcomes in BC and beyond. But the path from the lab to a market-ready product is long and fraught with its own set of challenges. As part of MSFHR’s commitment to address gaps in BC’s health research ecosystem, the Foundation is preparing to launch the new Innovation to Commercialization (I2C) Program.
The I2C Program will help researchers navigate the gap between discovery and practical application by providing funding to support researchers in the health and health services sectors advance their discoveries or inventions towards commercialization resulting in products or technologies that improve health outcomes, and enrich the health innovation ecosystem of BC.
Translational researchers in the health and health services sectors will be invited to apply for I2C awards to support feasibility research and commercialization activities to determine and improve the commercial viability of their intellectual property. These awards will provide funding support to a portion of the recipients’ salaries and/or research personnel directly associated with the award recipient’s proposed research, and for activities directly related to implementation of a commercialization plan.
The I2C Program is anticipated to launch in February 2017. Guidelines will be posted early in 2017.
For more information on the I2C Program, please visit the program page.
If you are a health research funder interested in co-funding an I2C award please visit our partnership pages.